共 50 条
- [41] A phase Ia/Ib, first-in-human, dose-escalation study evaluating the safety, tolerability, and efficacy of IOS-1002, a LILRB1, LILRB2, and KIR3DL1 targeting HLA-derived fusion protein administered alone or in combination with a PD-1 antibody in patients with advanced solid tumors ANNALS OF ONCOLOGY, 2023, 34 : S494 - S494
- [44] Genetic polymorphisms and expression of HLA-G and its receptors, KIR2DL4 and LILRB1, in non-small cell lung cancer TISSUE ANTIGENS, 2015, 85 (06): : 466 - 475
- [48] Carrying certain KIR3DL1 alleles with HLA-B*57 is associated with protection from HIV infection M S-MEDECINE SCIENCES, 2008, 24 (12): : 1030 - 1032
- [50] Contribution of KIR3DL1/3DS1 to ankylosing spondylitis in human leukocyte antigen-B27 Caucasian populations Arthritis Research & Therapy, 8